Meet in the middle: Could cell mediated-immunity assays be the answer for ideal Cytomegalovirus prophylaxis after lung transplantation? Observational study from a single center with intermittent antiviral prophylaxis.
Silvia Vidal CamposLisete Ribeiro TeixeiraMaristela Pinnheiro FreireAna Carolina MamanaClarisse Martins MachadoPublished in: Transplant infectious disease : an official journal of the Transplantation Society (2023)
QuantiFERON-CMV may be another diagnostic tool to help stratify CMV-disease risk and individualized antiviral prophylaxis after LTx.